30 years of purification innovation

For over 30 years, we have helped you, our customers, accelerate your process development by providing innovative chromatography solutions for biotherapeutic manufacturing. To support you, we provide novel affinity technologies and robust polish resins along with experienced technical guidance to help you optimize your downstream process. This year, we are excited to celebrate three decades of purification solutions, of supporting your discoveries and helping you make the world healthier.

Discover our milestones in purification innovation

From our first POROS products to the launch of our CaptureSelect affinity resins, navigate through our milestones to learn about the technologies and when they were used to manufacture lifechanging therapies  

1992 milestone POROS chromatography launch
1995 milestone identification of Camelid single-domain antibodies
1997 milestone POROS resin used to target CD20
1998 milestone POROS used to target RSV protein F
2003 milestone POROS HS used to develop HPV vaccine
2003  milestone CaptureSelect used for capture of human serum albumin
2009 milestone POROS XS sets standard for cation exchange chromatography
2014 milestone launch of Capture Select antibody affinity resin
2015 milestone launch of CaptureSelect AAV8 and AAV9
2015 milestone CaptureSelect used for hemophilia biotherapeutic
2019 milestone CaptureSelect C-tag affinity matrix used for malaria vaccine
2020 milestone POROS Oligo (dT)25 designed for isolation of mRNA
1992 milestone POROS chromatography launch
1995 milestone identification of Camelid single-domain antibodies
1997 milestone POROS resin used to target CD20
1998 milestone POROS used to target RSV protein F
2003 milestone POROS HS used to develop HPV vaccine
2003  milestone CaptureSelect used for capture of human serum albumin
2009 milestone POROS XS sets standard for cation exchange chromatography
2014 milestone launch of Capture Select antibody affinity resin
2015 milestone launch of CaptureSelect AAV8 and AAV9
2015 milestone CaptureSelect used for hemophilia biotherapeutic
2019 milestone CaptureSelect C-tag affinity matrix used for malaria vaccine
2020 milestone POROS Oligo (dT)25 designed for isolation of mRNA

Optimize your downstream process with our purification solutions

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:

POROS: Pharmaceutical Grade Reagent. For Manufacturing and Laboratory Use Only.

CaptureSelect: For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.